TrialEuropean journal of cancer (Oxford, England : 1990)2025

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).

Francesca Battaglin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.